A composite preparation for treating HP (helicobacter pylori)

A Helicobacter pylori preparation technology, applied in the field of drugs for the treatment of Helicobacter pylori, to achieve the effect of increasing AUC, increasing blood drug concentration, and reducing drug resistance rate

Inactive Publication Date: 2006-12-13
GUANGZHOU YOUYI PHARMA SCI & TECH DEV +1
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] So far, in the prior art, the combination preparation of omeprazole and clarithromycin has not been seen in China to treat Helicobacter pylori in combination

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Enteric-coated tablet prescription containing 20 mg of active ingredients omeprazole and 250 mg of clarithromycin per tablet:

[0038] Omeprazole 20g

[0039] Clarithromycin 250g

[0040] Mannitol 65g

[0041] Lactose 45g

[0042] Poloxamer 1g

[0043] PVP 6g

[0044] Magnesium stearate 8g

[0045] Talc powder 20g

[0046] Acrylic No. 2 Resin 5g

[0047] Appropriate amount of diethyl phthalate

[0048] Specific preparation method:

[0049] Put 20 g of omeprazole, 250 g of clarithromycin, 65 g of mannitol, and 45 g of lactose through a 100-mesh sieve into a KJz-10 type fast stirring granulator and mix at high speed for 2 minutes, and dissolve 1 g of poloxamer in Add 15ml of 5% PVP in absolute ethanol solution as a binder. Quickly mix for 3 minutes. Quickly granulate for 2 minutes. Take it out and dry it in a vacuum oven for 4 hours. Sieve the granules with a 16-mesh sieve and add an appropriate amount of magnesium stearate. , pressed into plain tablets. Add ta...

Embodiment 2

[0051] Prescription of enteric-coated tablets containing 20 mg of active ingredients omeprazole and 500 mg of clarithromycin per tablet:

[0052] Omeprazole 20g

[0053] Clarithromycin 500g

[0054] Mannitol 65g

[0055] Lactose 45g

[0056] Poloxamer 1g

[0057] PVP 6g

[0058] Magnesium stearate 8g

[0059] Talc powder 20g

[0060] Acrylic No. 2 Resin 5g

[0061] Appropriate amount of diethyl phthalate

[0062] Preparation:

[0063] With this prescription, basically according to the preparation method of Example 1, a total of 1000 omeprazole clarithromycin enteric-coated tablets were produced, each containing 10 mg of omeprazole and 500 mg of clarithromycin.

Embodiment 3

[0065] Prescription for each capsule containing the active ingredients omeprazole 20mg and clarithromycin 250mg:

[0066] Omeprazole 20g

[0067] Clarithromycin 250g

[0068] Mannitol 60g

[0069] Lactose 40g

[0070] Poloxamer 1.5g

[0071] PVP 6g

[0072] Magnesium stearate 8g

[0073] Talc powder 20g

[0074] Acrylic No. 2 Resin 5g

[0075] Appropriate amount of diethyl phthalate

[0076] Specific preparation method:

[0077] Preparation of omeprazole enteric-coated granules: Take 20 g of omeprazole, 60 g of mannitol, and 40 g of lactose that have been passed through a 100-mesh sieve and place them in a KJz-10 type fast stirring granulator for 2 minutes at high speed, and mix the poloxamer Dissolve about 1g of poloxamer in 15ml of 5% PVP absolute ethanol solution as a binder, add, mix quickly for 3 minutes, granulate quickly for 2 minutes, take it out, dry in a vacuum oven for 4 hours, and use a 24-40 mesh sieve whole grain. Add talc powder into 5% PVP absolute e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a composite preparation of Omepraxole and Clarithromycin, wherein the weight ratio of the active constituents Omepraxole and Clarithromycin is 1:10-1:50, the preparation can be used for treating diseases such as Helicobacter Pylori infection.

Description

technical field [0001] The invention relates to a medicine for treating Helicobacter pylori, more specifically, the invention relates to a combined preparation of omeprazole and clarithromycin for treating Helicobacter pylori. Background technique [0002] Peptic ulcer may be caused by Helicobacter pylori (HP) infection. The ecologically suitable environment for Helicobacter pylori is human gastric epithelial cells, and other Helicobacter species reside in various animal hosts. High adaptability keeps it from being eliminated during migration, which depends on HP's movement ability and urease activity, as well as the special adhesin it produces. After HP infection, if it is not treated, it will usually persist in the host for life. [0003] Omeprazole is a proton pump inhibitor (PPI) that blocks gastric acid secretion from various causes. After PPI enters the human body, the action time can reach more than 24 hours, so the acid suppression intensity of PPI is strong and t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K9/10A61K9/16A61K9/20A61K9/48A61P31/04A61P1/04A61K31/4439
Inventor 张志生陈满英康秋萍李云霞
Owner GUANGZHOU YOUYI PHARMA SCI & TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products